Copyright Reports & Markets. All rights reserved.

Global CRISPR Genome Editing Market Growth (Status and Outlook) 2019-2024

Buy now

Table of Contents

    2019-2024 Global CRISPR Genome Editing Market Report (Status and Outlook)

      1 Scope of the Report

      • 1.1 Market Introduction
      • 1.2 Research Objectives
      • 1.3 Years Considered
      • 1.4 Market Research Methodology
      • 1.5 Economic Indicators
      • 1.6 Currency Considered

      2 Executive Summary

      • 2.1 World Market Overview
        • 2.1.1 Global CRISPR Genome Editing Market Size 2014-2024
        • 2.1.2 CRISPR Genome Editing Market Size CAGR by Region
      • 2.2 CRISPR Genome Editing Segment by Type
        • 2.2.1 Genetic Engineering
        • 2.2.2 Gene Library
        • 2.2.3 Human Stem Cells
        • 2.2.4 Others
      • 2.3 CRISPR Genome Editing Market Size by Type
        • 2.3.1 Global CRISPR Genome Editing Market Size Market Share by Type (2014-2019)
        • 2.3.2 Global CRISPR Genome Editing Market Size Growth Rate by Type (2014-2019)
      • 2.4 CRISPR Genome Editing Segment by Application
        • 2.4.1 Biotechnology Companies
        • 2.4.2 Pharmaceutical Companies
        • 2.4.3 Others
      • 2.5 CRISPR Genome Editing Market Size by Application
        • 2.5.1 Global CRISPR Genome Editing Market Size Market Share by Application (2014-2019)
        • 2.5.2 Global CRISPR Genome Editing Market Size Growth Rate by Application (2014-2019)

      3 Global CRISPR Genome Editing by Players

      • 3.1 Global CRISPR Genome Editing Market Size Market Share by Players
        • 3.1.1 Global CRISPR Genome Editing Market Size by Players (2017-2019)
        • 3.1.2 Global CRISPR Genome Editing Market Size Market Share by Players (2017-2019)
      • 3.2 Global CRISPR Genome Editing Key Players Head office and Products Offered
      • 3.3 Market Concentration Rate Analysis
        • 3.3.1 Competition Landscape Analysis
        • 3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
      • 3.4 New Products and Potential Entrants
      • 3.5 Mergers & Acquisitions, Expansion

      4 CRISPR Genome Editing by Regions

      • 4.1 CRISPR Genome Editing Market Size by Regions
      • 4.2 Americas CRISPR Genome Editing Market Size Growth
      • 4.3 APAC CRISPR Genome Editing Market Size Growth
      • 4.4 Europe CRISPR Genome Editing Market Size Growth
      • 4.5 Middle East & Africa CRISPR Genome Editing Market Size Growth

      5 Americas

      • 5.1 Americas CRISPR Genome Editing Market Size by Countries
      • 5.2 Americas CRISPR Genome Editing Market Size by Type
      • 5.3 Americas CRISPR Genome Editing Market Size by Application
      • 5.4 United States
      • 5.5 Canada
      • 5.6 Mexico
      • 5.7 Key Economic Indicators of Few Americas Countries

      6 APAC

      • 6.1 APAC CRISPR Genome Editing Market Size by Countries
      • 6.2 APAC CRISPR Genome Editing Market Size by Type
      • 6.3 APAC CRISPR Genome Editing Market Size by Application
      • 6.4 China
      • 6.5 Japan
      • 6.6 Korea
      • 6.7 Southeast Asia
      • 6.8 India
      • 6.9 Australia
      • 6.10 Key Economic Indicators of Few APAC Countries

      7 Europe

      • 7.1 Europe CRISPR Genome Editing by Countries
      • 7.2 Europe CRISPR Genome Editing Market Size by Type
      • 7.3 Europe CRISPR Genome Editing Market Size by Application
      • 7.4 Germany
      • 7.5 France
      • 7.6 UK
      • 7.7 Italy
      • 7.8 Russia
      • 7.9 Spain
      • 7.10 Key Economic Indicators of Few Europe Countries

      8 Middle East & Africa

      • 8.1 Middle East & Africa CRISPR Genome Editing by Countries
      • 8.2 Middle East & Africa CRISPR Genome Editing Market Size by Type
      • 8.3 Middle East & Africa CRISPR Genome Editing Market Size by Application
      • 8.4 Egypt
      • 8.5 South Africa
      • 8.6 Israel
      • 8.7 Turkey
      • 8.8 GCC Countries

      9 Market Drivers, Challenges and Trends

      • 9.1 Market Drivers and Impact
        • 9.1.1 Growing Demand from Key Regions
        • 9.1.2 Growing Demand from Key Applications and Potential Industries
      • 9.2 Market Challenges and Impact
      • 9.3 Market Trends

      10 Global CRISPR Genome Editing Market Forecast

      • 10.1 Global CRISPR Genome Editing Market Size Forecast (2019-2024)
      • 10.2 Global CRISPR Genome Editing Forecast by Regions
        • 10.2.1 Global CRISPR Genome Editing Forecast by Regions (2019-2024)
        • 10.2.2 Americas Market Forecast
        • 10.2.3 APAC Market Forecast
        • 10.2.4 Europe Market Forecast
        • 10.2.5 Middle East & Africa Market Forecast
      • 10.3 Americas Forecast by Countries
        • 10.3.1 United States Market Forecast
        • 10.3.2 Canada Market Forecast
        • 10.3.3 Mexico Market Forecast
        • 10.3.4 Brazil Market Forecast
      • 10.4 APAC Forecast by Countries
        • 10.4.1 China Market Forecast
        • 10.4.2 Japan Market Forecast
        • 10.4.3 Korea Market Forecast
        • 10.4.4 Southeast Asia Market Forecast
        • 10.4.5 India Market Forecast
        • 10.4.6 Australia Market Forecast
      • 10.5 Europe Forecast by Countries
        • 10.5.1 Germany Market Forecast
        • 10.5.2 France Market Forecast
        • 10.5.3 UK Market Forecast
        • 10.5.4 Italy Market Forecast
        • 10.5.5 Russia Market Forecast
        • 10.5.6 Spain Market Forecast
      • 10.6 Middle East & Africa Forecast by Countries
        • 10.6.1 Egypt Market Forecast
        • 10.6.2 South Africa Market Forecast
        • 10.6.3 Israel Market Forecast
        • 10.6.4 Turkey Market Forecast
        • 10.6.5 GCC Countries Market Forecast
      • 10.7 Global CRISPR Genome Editing Forecast by Type
      • 10.8 Global CRISPR Genome Editing Forecast by Application

      11 Key Players Analysis

      • 11.1 Editas Medicine
        • 11.1.1 Company Details
        • 11.1.2 CRISPR Genome Editing Product Offered
        • 11.1.3 Editas Medicine CRISPR Genome Editing Revenue, Gross Margin and Market Share (2017-2019)
        • 11.1.4 Main Business Overview
        • 11.1.5 Editas Medicine News
      • 11.2 CRISPR Therapeutics
        • 11.2.1 Company Details
        • 11.2.2 CRISPR Genome Editing Product Offered
        • 11.2.3 CRISPR Therapeutics CRISPR Genome Editing Revenue, Gross Margin and Market Share (2017-2019)
        • 11.2.4 Main Business Overview
        • 11.2.5 CRISPR Therapeutics News
      • 11.3 Horizon Discovery
        • 11.3.1 Company Details
        • 11.3.2 CRISPR Genome Editing Product Offered
        • 11.3.3 Horizon Discovery CRISPR Genome Editing Revenue, Gross Margin and Market Share (2017-2019)
        • 11.3.4 Main Business Overview
        • 11.3.5 Horizon Discovery News
      • 11.4 Sigma-Aldrich
        • 11.4.1 Company Details
        • 11.4.2 CRISPR Genome Editing Product Offered
        • 11.4.3 Sigma-Aldrich CRISPR Genome Editing Revenue, Gross Margin and Market Share (2017-2019)
        • 11.4.4 Main Business Overview
        • 11.4.5 Sigma-Aldrich News
      • 11.5 Genscript
        • 11.5.1 Company Details
        • 11.5.2 CRISPR Genome Editing Product Offered
        • 11.5.3 Genscript CRISPR Genome Editing Revenue, Gross Margin and Market Share (2017-2019)
        • 11.5.4 Main Business Overview
        • 11.5.5 Genscript News
      • 11.6 Sangamo Biosciences
        • 11.6.1 Company Details
        • 11.6.2 CRISPR Genome Editing Product Offered
        • 11.6.3 Sangamo Biosciences CRISPR Genome Editing Revenue, Gross Margin and Market Share (2017-2019)
        • 11.6.4 Main Business Overview
        • 11.6.5 Sangamo Biosciences News
      • 11.7 Lonza Group
        • 11.7.1 Company Details
        • 11.7.2 CRISPR Genome Editing Product Offered
        • 11.7.3 Lonza Group CRISPR Genome Editing Revenue, Gross Margin and Market Share (2017-2019)
        • 11.7.4 Main Business Overview
        • 11.7.5 Lonza Group News
      • 11.8 Integrated DNA Technologies
        • 11.8.1 Company Details
        • 11.8.2 CRISPR Genome Editing Product Offered
        • 11.8.3 Integrated DNA Technologies CRISPR Genome Editing Revenue, Gross Margin and Market Share (2017-2019)
        • 11.8.4 Main Business Overview
        • 11.8.5 Integrated DNA Technologies News
      • 11.9 New England Biolabs
        • 11.9.1 Company Details
        • 11.9.2 CRISPR Genome Editing Product Offered
        • 11.9.3 New England Biolabs CRISPR Genome Editing Revenue, Gross Margin and Market Share (2017-2019)
        • 11.9.4 Main Business Overview
        • 11.9.5 New England Biolabs News
      • 11.10 Origene Technologies
        • 11.10.1 Company Details
        • 11.10.2 CRISPR Genome Editing Product Offered
        • 11.10.3 Origene Technologies CRISPR Genome Editing Revenue, Gross Margin and Market Share (2017-2019)
        • 11.10.4 Main Business Overview
        • 11.10.5 Origene Technologies News
      • 11.11 Transposagen Biopharmaceuticals
      • 11.12 Thermo Fisher Scientific
      • 11.13 Caribou Biosciences
      • 11.14 Precision Biosciences
      • 11.15 Cellectis
      • 11.16 Intellia Therapeutics

      12 Research Findings and Conclusion

      CRISPR Genome editing is a group of technologies that give scientists the ability to change CRISPR.

      According to this study, over the next five years the CRISPR Genome Editing market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global revenue market share of key companies in CRISPR Genome Editing business, shared in Chapter 3.

      This report presents a comprehensive overview, market shares and growth opportunities of CRISPR Genome Editing market by product type, application, key companies and key regions.

      This study considers the CRISPR Genome Editing value generated from the sales of the following segments:

      Segmentation by product type: breakdown data from 2014 to 2019 in Section 2.3; and forecast to 2024 in section 10.7.
      Genetic Engineering
      Gene Library
      Others
      Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 10.8.
      Biotechnology Companies
      Pharmaceutical Companies
      Others

      This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
      Americas
      United States
      Canada
      Mexico
      Brazil
      APAC
      China
      Japan
      Korea
      Southeast Asia
      India
      Australia
      Europe
      Germany
      France
      UK
      Italy
      Russia
      Spain
      Middle East & Africa
      Egypt
      South Africa
      Israel
      Turkey
      GCC Countries

      The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
      Editas Medicine
      CRISPR Therapeutics
      Horizon Discovery
      Sigma-Aldrich
      Genscript
      Sangamo Biosciences
      Lonza Group
      Integrated DNA Technologies
      New England Biolabs
      Origene Technologies
      Transposagen Biopharmaceuticals
      Thermo Fisher Scientific
      Caribou Biosciences
      Precision Biosciences
      Cellectis
      Intellia Therapeutics

      In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

      Research objectives
      To study and analyze the global CRISPR Genome Editing market size by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
      To understand the structure of CRISPR Genome Editing market by identifying its various subsegments.
      Focuses on the key global CRISPR Genome Editing players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
      To analyze the CRISPR Genome Editing with respect to individual growth trends, future prospects, and their contribution to the total market.
      To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
      To project the size of CRISPR Genome Editing submarkets, with respect to key regions (along with their respective key countries).
      To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
      To strategically profile the key players and comprehensively analyze their growth strategies.

      Buy now